121 followers
RT @RespiratoryBMC: New: Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in #COPD: FLAME-based modelling in…
RT @RespiratoryBMC: New: Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in #COPD: FLAME-based modelling in…
Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population https://t.co/IYvjcJwsNW
#respiratoryresearch Indacaterol/glycopyrronium is cost-effective compared to salmeterol… https://t.co/xgDXbEmjCc
RT @RespiratoryBMC: New: Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in #COPD: FLAME-based modelling in…